CHICAGO, June 28, 2016 /PRNewswire/ --
New Life Sciences Solution
Supports, Enables and Simplifies Compliance Across all
Four Stages of the IDMP Maturity Curve with a Single
Platform
CSC (NYSE: CSC), a global leader in next-generation IT services
and solutions, today announced the launch of Identification of
Medicinal Products As-a Service (IDMPaaS), a collaboration with
ArisGlobal to deliver a cloud-hosted offering for life sciences
companies.
IDMPaaS provides access to regulatory information management
(RIM) solutions, drug safety monitoring software for
pharmacovigilance, business process services, and risk management
analytics to achieve compliance with emerging IDMP
requirements.
IDMPaaS includes initial consulting to help life sciences
organizations understand their IDMP responsibilities, along with
CSC's FirstDoc for content management and ArisGlobal's agIDMP for
data collection, review and submission - both delivered through a
data factory hosted in CSC's secure cloud environment. The result
is a service package designed to scale in response to the evolving
needs of life sciences organizations as they progress through the
four stages of the IDMP maturity curve - foundation, data
management, compliance, and business benefits.
In addition, CSC has entered into an agreement with ArisGlobal
to sell, host and support ArisGlobal's RIM and IDMP products. The
agreement will provide clients with an implementation partner that
has proven life sciences expertise for ArisGlobal's products on a
global scale. It also creates a platform approach to RIM and IDMP
solution provision.
"IDMP regulatory uncertainty and delays in guidance are rippling
through the industry, creating new problems for life science CIOs
(risk, uncertainty, unclear compliance requirements and so on),"
wrote Michael Shanler of Gartner.
"As the IDMP deadline approaches, life science CIOs must quickly
transition from gap analysis to solidifying the short-term
compliance efforts, and balance those with long-term vision as
those initial investments are made. Strategy determination is
complicated by the comprehensiveness of the data integration
required across a broad swath of IT applications and choice that it
presents in short- and long-range
objectives."[1]
IDMP is a set of emerging international standards designed to
provide a common, consistent and unambiguous way of identifying
medicinal products across different regions of the world. The
intent is to simplify and improve a range of regulatory activities,
including product registration, lifecycle management,
pharmacovigilance and risk management.
"CSC helps life sciences enterprises innovate and grow by
digitizing the life sciences value chain," said Steve Andrade, global general manager, CSC Life
Sciences. "We have a strong position providing innovative products
and services that support regulatory information management, and we
are looking to address the point where RIM and IDMP come together.
CSC's strength as a global enterprise and industry expertise bring
the scale to support the largest life sciences organizations in the
world."
"We've been providing advice and guidance on IDMP to our clients
for a number of years," said Joel
Finkle, head of CSC's IDMP practice. "Through those
engagements, it has become clear
that clients need an integrated approach to drive pace and
efficiency, which is why we've designed IDMPaaS - a first of type
complete solution."
"CSC and ArisGlobal have complementary products and share a
vision of using digital transformation to provide value to life
sciences organizations," said Deepak
Abbhi, chief executive officer of ArisGlobal. "It makes
great sense for our two organizations to work together to
streamline the way our mutual customers address their IDMP
responsibilities."
CSC in Life Sciences
CSC has been delivering innovative technology solutions to life
sciences for over ten years, and is a leading provider of
regulatory information management (RIM) solutions and business
process services. CSC leverages its extensive software capability
to build products and services that help digitize the life sciences
value chain. Learn more about how ArisGlobal and CSC align to
deliver a scalable IDMP platform during a recent Town Hall. Read
more about the digital transformation journey of healthcare and
life sciences organizations.
[1] Gartner, Delayed and
Confusing IDMP Compliance Requirements Demand Life Science CIOs
Pursue a Two-Part Strategy, Michael
Shanler 21 January
2016
About CSC
CSC (NYSE: CSC) leads clients on their digital transformation
journeys. The company provides innovative next-generation
technology services and solutions that leverage deep industry
expertise, global scale, technology independence and an extensive
partner community. CSC serves leading commercial and international
public sector organizations, including some of the world's leading
healthcare providers. CSC is a Fortune 500 company and ranked among
the best corporate citizens. For more information, visit us at
http://www.csc.com and http://www.csc.com/healthcare.
About ArisGlobal
ArisGlobal's cloud-based solutions facilitate global drug
development and regulatory compliance within the life sciences and
healthcare industries. Its cloud platform supports the entire
product life cycle including clinical development, regulatory
affairs, pharmacovigilance and medical communications. Hundreds of
drug and device manufacturers, CROs and regulatory agencies
leverage ArisGlobal's advanced technology solutions to make better
and more informed decisions, facilitate compliance, reduce risk and
improve operational efficiency. Headquartered in the United States, ArisGlobal® has
regional offices in Europe,
India and Japan. For more information, visit us at
http://www.arisglobal.com.
Contact:
Nicole Drapeau Gillen
Director, Product Marketing
Arisglobal LLC
Mobile: +1-609-360-4082
ngillen@arisglobal.com
SOURCE ArisGlobal